Radiopharm Theranostics Limited American Depositary Shares (RADX)

• Market cap: $11.8B
• 1 day: 2.89%
• 5 days: -2.91%
• 1 month: 19.20%
• 3 months: -69.78%
• 6 months: -69.78%
• Year to date: 15.09%
• 1 year: -69.78%
• 5 years: -69.78%
• 10 years: -69.78%

About: Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.